About
Akebia Therapeutics is a fully integrated biopharmaceutical company developing and delivering therapies for patients with kidney disease, including two FDA-approved products that target complications of chronic kidney disease.
Explore Akebia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.